We are live on ! Find out more
AAP

Arax Advisory Partners Portfolio holdings

AUM $3.54B
1-Year Est. Return 19.14%
This Fund
S&P 500
This Quarter Est. Return
+8.04%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
AUM
$2.18B
AUM Growth
+$617M
Cap. Flow
+$399M
Cap. Flow %
18.35%
Top 10 Hldgs %
22.83%
Holding
3,224
New
565
Increased
1,310
Reduced
679
Closed
193

Sector Composition

Rank Sector Weight
1 Technology 6.5%
2 Financials 4.24%
3 Healthcare 3.21%
4 Consumer Discretionary 2.76%
5 Industrials 2.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BAC icon
151
Bank of America
BAC
$440B
$2.06M 0.09%
39,334
-6,180
-14% -$260K
VCLT icon
152
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.88B
$2.05M 0.09%
27,075
-468
-2% -$34.6K
HEI.A icon
153
HEICO Corp Class A
HEI.A
$37.2B
$2.05M 0.09%
7,787
+1,059
+16% +$232K
QQQM icon
154
Invesco NASDAQ 100 ETF
QQQM
$102B
$2.03M 0.09%
8,940
+5,073
+131% +$1.04M
PM icon
155
Philip Morris
PM
$291B
$2M 0.09%
10,239
+5,994
+141% +$1.03M
TDG icon
156
TransDigm Group
TDG
$71.3B
$1.96M 0.09%
1,286
+108
+9% +$152K
MCO icon
157
Moody's
MCO
$83.8B
$1.93M 0.09%
3,784
+881
+30% +$408K
SDY icon
158
State Street SPDR S&P Dividend ETF
SDY
$23.8B
$1.86M 0.09%
13,712
+12,907
+1,603% +$1.71M
ISRG icon
159
Intuitive Surgical
ISRG
$130B
$1.83M 0.08%
3,374
+396
+13% +$207K
NCLO
160
Nuveen AA-BBB CLO ETF
NCLO
$152M
$1.79M 0.08%
+71,190
New +$1.78M
VHT icon
161
Vanguard Health Care ETF
VHT
$18.2B
$1.77M 0.08%
7,145
+784
+12% +$194K
FULT icon
162
Fulton Financial
FULT
$4.76B
$1.76M 0.08%
91,902
+779
+0.9% +$13.3K
AMD icon
163
Advanced Micro Devices
AMD
$846B
$1.73M 0.08%
3,939
+1,032
+36% +$112K
CVX icon
164
Chevron
CVX
$379B
$1.72M 0.08%
10,822
+1,158
+12% +$163K
CRM icon
165
Salesforce
CRM
$156B
$1.71M 0.08%
6,265
+2,641
+73% +$706K
TSM icon
166
TSMC
TSM
$2.16T
$1.7M 0.08%
6,720
+1,445
+27% +$268K
XDSQ icon
167
Innovator US Equity Accelerated ETF Quarterly
XDSQ
$71.9M
$1.67M 0.08%
44,754
-170
-0.4% -$6.02K
MCK icon
168
McKesson
MCK
$97.2B
$1.67M 0.08%
2,273
+922
+68% +$651K
EFA icon
169
iShares MSCI EAFE ETF
EFA
$79.3B
$1.64M 0.08%
2,225
+591
+36% +$50.5K
DIS icon
170
Walt Disney
DIS
$170B
$1.63M 0.07%
11,022
-363
-3% -$37.7K
PG icon
171
Procter & Gamble
PG
$345B
$1.62M 0.07%
7,383
+1,879
+34% +$307K
SCHV
172
Schwab US Large-Cap Value ETF
SCHV
$16.1B
$1.62M 0.07%
57,185
+56,990
+29,226% +$1.5M
T icon
173
AT&T
T
$160B
$1.61M 0.07%
55,614
-15,914
-22% -$439K
DUK icon
174
Duke Energy
DUK
$96.9B
$1.56M 0.07%
13,180
+4,414
+50% +$521K
FXL icon
175
First Trust Technology AlphaDEX Fund
FXL
$2.77B
$1.54M 0.07%
9,803
+577
+6% +$81.8K

Similar funds

Arax Advisory Partners's Q2 2025 Portfolio in Review

As of Q2 2025, Arax Advisory Partners held 3,224 positions worth $2.18B, up 40% from $1.56B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Arax Advisory Partners deployed $399M of net new capital in Q2 2025, opening 565 new positions and adding to 1,310 existing holdings. Its largest new stake was Panagram BBB-B CLO ETF: 1,423,147 shares worth $38.1M.

By sector, the portfolio is most concentrated in Technology at 6.5% of assets, up from 5.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, an estimated $21.9M trimmed.

  • Arax Advisory Partners's largest Q2 2025 buy was Panagram BBB-B CLO ETF: 1,423,147 shares worth $38.1M.
  • Arax Advisory Partners added most to Axon Enterprise in Q2 2025, an estimated $52.4M increase.
  • Arax Advisory Partners's biggest Q2 2025 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $21.9M.
  • Arax Advisory Partners fully exited YieldMax MSTR Option Income Strategy ETF in Q2 2025, selling an estimated $102K.
  • Arax Advisory Partners's ten largest holdings make up 23% of its $2.18B portfolio in Q2 2025.
  • Arax Advisory Partners opened 565 new positions and closed 193 in Q2 2025.
  • Arax Advisory Partners's portfolio value rose 40% quarter-over-quarter to $2.18B.

Based on Arax Advisory Partners's 13F filing for Q2 2025, filed 12 Aug 2025.